E3 ubiquitin ligase-mediated regulation of bone formation and tumorigenesis

被引:0
作者
N Sévère
F-X Dieudonné
P J Marie
机构
[1] Laboratory of Osteoblast Biology and Pathology,
[2] INSERM U606,undefined
[3] University Paris Diderot,undefined
[4] Sorbonne Paris Cité,undefined
来源
Cell Death & Disease | 2013年 / 4卷
关键词
ubiquitin ligases; proteasome; receptor tyrosine kinases; bone tumors; Cbl proteins; ubiquitination;
D O I
暂无
中图分类号
学科分类号
摘要
The ubiquitination–proteasome and degradation system is an essential process that regulates protein homeostasis. This system is involved in the regulation of cell proliferation, differentiation and survival, and dysregulations in this system lead to pathologies including cancers. The ubiquitination system is an enzymatic cascade that mediates the marking of target proteins by an ubiquitin label and thereby directs their degradation through the proteasome pathway. The ubiquitination of proteins occurs through a three-step process involving ubiquitin activation by the E1 enzyme, allowing for the transfer to a ubiquitin-conjugated enzyme E2 and to the targeted protein via ubiquitin-protein ligases (E3), the most abundant group of enzymes involved in ubiquitination. Significant advances have been made in our understanding of the role of E3 ubiquitin ligases in the control of bone turnover and tumorigenesis. These ligases are implicated in the regulation of bone cells through the degradation of receptor tyrosine kinases, signaling molecules and transcription factors. Initial studies showed that the E3 ubiquitin ligase c-Cbl, a multi-domain scaffold protein, regulates bone resorption by interacting with several molecules in osteoclasts. Further studies showed that c-Cbl controls the ubiquitination of signaling molecules in osteoblasts and in turn regulates osteoblast proliferation, differentiation and survival. Recent data indicate that c-Cbl expression is decreased in primary bone tumors, resulting in excessive receptor tyrosine kinase signaling. Consistently, c-Cbl ectopic expression reduces bone tumorigenesis by promoting tyrosine kinase receptor degradation. Here, we review the mechanisms of action of E3 ubiquitin ligases in the regulation of normal and pathologic bone formation, and we discuss how targeting the interactions of c-Cbl with some substrates may be a potential therapeutic strategy to promote osteogenesis and to reduce tumorigenesis.
引用
收藏
页码:e463 / e463
相关论文
共 580 条
[1]  
Ciechanover A(2005)Intracellular protein degradation: from a vague idea, through the lysosome and the ubiquitin-proteasome system, and onto human diseases and drug targeting Cell Death Differ 12 1178-1190
[2]  
Komander D(2009)The emerging complexity of protein ubiquitination Biochem Soc Trans 37 937-953
[3]  
Dikic I(2009)Ubiquitin-binding domains - from structures to functions Nat Rev Mol Cell Biol 10 659-671
[4]  
Wakatsuki S(2009)Breaking the chains: structure and function of the deubiquitinases Nat Rev Mol Cell Biol 10 550-563
[5]  
Walters KJ(2006)The ubiquitin proteolytic system: from an idea to the patient bed Proc Am Thorac Soc 3 21-31
[6]  
Komander D(2012)Ubiquitin ligases and beyond BMC Biol 10 22-322
[7]  
Clague MJ(2012)Ubiquitin-binding proteins: decoders of ubiquitin-mediated cellular functions Annu Rev Biochem 81 291-1402
[8]  
Urbe S(2011)Ubiquitination of E3 ligases: self-regulation of the ubiquitin system via proteolytic and non-proteolytic mechanisms Cell Death Differ 18 1393-243
[9]  
Ciechanover A(2011)Advances in osteoclast biology: old findings and new insights from mouse models Nat Rev Rheumatol 7 235-355
[10]  
Dikic I(2003)Control of osteoblast function and regulation of bone mass Nature 423 349-21